I. Isenberg. 5-HT induces duodenal mucosal bicarbonate secretion via cAMP-and Ca 2ϩ -dependent signaling pathways and 5-HT 4 receptors in mice. Am J Physiol Gastrointest Liver Physiol 286: G444-G451, 2004. First published October 23, 2003 10.1152/ ajpgi.00105.2003In previous studies, we have found that 5-hydroxytryptamine (5-HT) is a potent stimulant of duodenal mucosal bicarbonate secretion (DMBS) in mice. The aim of the present study was to determine the intracellular signaling pathways and 5-HT receptor subtypes involved in 5-HT-induced DMBS. Bicarbonate secretion by murine duodenal mucosa was examined in vitro in Ussing chambers. 5-HT receptor involvement in DMBS was inferred from pharmacological studies by using selective 5-HT receptor antagonists and agonists. The expression of 5-HT4 receptor mRNA in duodenal mucosa and epithelial cells was analyzed by RT-PCR. cAMP-dependent signaling pathway inhibitors MDL-12330A, RpcAMP, and H-89 and Ca 2ϩ -dependent signaling pathway inhibitors verapamil and W-13 markedly reduced 5-HT-stimulated duodenal bicarbonate secretion and short-circuit current (I sc), whereas cGMPdependent signaling pathway inhibitors NS-2028 and KT-5823 failed to alter these responses. Both SB-204070 and high-dose ICS-205930 (selective 5-HT4 receptor antagonists) markedly inhibited 5-HT-stimulated bicarbonate secretion and Isc, whereas methiothepine (5-HT1 receptor antagonist), ketanserin (5-HT2 receptor antagonist), and a low concentration of ICS-205930 (5-HT 3 receptor antagonist) had no effect. RS-67506 (partial 5-HT 4 receptor agonist) concentration-dependently increased bicarbonate secretion and Isc, whereas 5-carboxamidotryptamine (5-HT1 receptor agonist), ␣-methyl-5-HT (5-HT2 receptor agonist), and phenylbiguanide (5-HT3 receptor agonist) did not significantly increase bicarbonate secretion or I sc. RT-PCR analysis confirmed the expression of 5-HT4 receptor mRNA in murine duodenal mucosa and epithelial cells. These results demonstrate that 5-HT regulates DMBS via both cAMP-and Ca 2ϩ -dependent signaling pathways and 5-HT4 receptors located in the duodenal mucosa and/or epithelial cells.
DUODENAL MUCOSAL BICARBONATE secretion plays an important role in duodenal mucosal protection against acid-peptic injury. A number of neural and humoral factors [such as prostaglandin E 2 , vasoactive intestinal peptide (48) , dopamine (13) , somatostatin (34) , luminal acid (19), etc.] are known to be involved in regulation of this physiological process.
5-Hydroxytryptamine (5-HT) is widely distributed in the gastrointestinal tract. More than 90% of 5-HT is localized within the enterochromaffin (EC) cells of gastrointestinal mucosal epithelia and enteric neurons (15, 42) . 5-HT is an important neurotransmitter and intercellular messenger. A variety of neural, humoral, and intraluminal stimuli have been shown to release 5-HT from EC cells (47) . 5-HT has been shown to participate in the regulation of gastrointestinal motility (31) , gastric acid secretion (27) , pancreatic secretion (44) , and intestinal chloride secretion (36) . Moreover, we recently showed that 5-HT is a potent stimulant of duodenal bicarbonate secretion (46) , but the signal transduction pathway(s) and the 5-HT receptor subtypes involved in the action of 5-HT on duodenal bicarbonate secretion were unknown. However, elucidation of such information is important given clinical usage of specific 5-HT receptor antagonists.
The 5-HT receptor population is comprised of several subtypes. Through pharmacological studies and molecular cloning (21, 22, 37) , at least seven families of 5-HT receptor subtypes, including 5-HT 1 , 5-HT 2 , 5-HT 3 , 5-HT 4 , 5-HT 5 , 5-HT 6 , and 5-HT 7 , have been discovered. 5-HT and its receptors are found both in the central and peripheral nervous systems, as well as in a number of nonneuronal tissues in the gastrointestinal tract, cardiovascular system, and blood. 5-HT 5 , 5-HT 6 , and 5-HT 7 receptors are cloned novel receptors with as yet undefined physiological correlates. On the other hand, according to the current classification, four main subtypes of 5-HT receptors, 5-HT 1 , 5-HT 2 , 5-HT 3 , and 5-HT 4 , can be distinguished functionally (21) , and these four 5-HT receptors are also recognized to exist in the gastrointestinal tract. Each subtype of 5-HT receptors is involved in various regulatory functions in different organs (21, 22) .
The aim of the present study was to further characterize the signal transduction pathway(s) and 5-HT receptor(s) that mediate duodenal mucosal bicarbonate secretion in mice.
MATERIALS AND METHODS
Chemicals and solutions. 5-HT, 5-carboxamidotryptamine (5-CT), ␣-methyl-5-HT, methiothepine, ketanserin, ICS-205930, SB-204070, MDL-12330A, H-89, Rp-cAMP, verapamil, W-13, and KN-62 were purchased from Sigma (St. Louis, MO). 1-Phenylbiguanide and RS-67506 were from Tocris (Ellisville, MO). KT-5823 and NS-2028 were from Calibochem (San Diego, CA). All other chemicals were obtained from Fisher Scientific (Santa Clara, CA). For Ussing chamber studies, the mucosal solution contained the following (in mM): 140 Na ϩ , 5. Animal preparation. Experiments were performed on White Swiss mice (6-10 wk of age). All studies were approved by the University of California-San Diego Committee on Investigations Involving Animals. The mice were housed in a standard animal care room with a 12:12-h light-dark cycle and were allowed free access to food and water. Before experiments, the mice were deprived of food and water for at least 1 h. After anesthesia with a cocktail of hypnorm and midazolam (10 ml/kg ip; Janssen Pharmaceutica, Beerse, Belgium), the abdomen was opened by a midline incision. The proximal duodenum (a portion stretching approximately from 2 mm distal to the pylorus to the common bile duct ampulla) was removed and immediately placed in ice-cold isosmolar mannitol and indomethacin (1 M) solution (to suppress trauma-induced prostaglandin release). The anesthetized mice were then killed by cervical dislocation. The duodenum was opened along the mesenteric border and stripped of external serosal and muscle layers by sharp dissection in the abovementioned ice-cold isosmolar mannitol and indomethacin solution.
Ussing chamber experiments. Mucosa was mounted between two Lucite half-chambers with an exposed area of 0. 
, or vehicular control was added to the serosal side. Recordings were then made over the subsequent 60-min test period as described above for 5-HT.
RNA extraction and RT-PCR. Expression of 5-HT4 receptor mRNA in duodenal mucosa and epithelial cells was studied by RT-PCR. Segments of duodenal mucosae (ϳ10 mg) were dissected free of seromuscular layers as described above for Ussing chamber experiments. For some studies, duodenal epithelial cells were further isolated according to a previously validated method (1) . In brief, a 7-mm segment of proximal duodenum was excised. The lumen was rinsed to remove the mucous layer. The luminal surface was then exposed to an EDTA-containing solution and vortexed briefly to facilitate cell detachment. Duodenal mucosa and isolated duodenal epithelial cells were homogenized and lysed separately. Total RNA was extracted by using the RNeasy mini kit (Qiagen). RNA was treated with RNasefree DNase to remove any contaminating genomic DNA. Total RNA from duodenal mucosa or epithelial cells was converted into singlestranded cDNA by using Sensiscript reverse transcriptase (Qiagen) with oligo(dT)12-18 primer (0.5 g/l). The PCR reaction was carried out in a 50-l reaction mixture by using Taq PCR Core Kit (Qiagen). The primer pairs for 5-HT4 receptor were sense 1 (5Ј-ATG GTC AAC AAG CCC TAT GC-3Ј) and antisense 1 (AGG AAG GCA CGT CTG AAA GA-3Ј), corresponding, respectively, to bases 561-580 and 954-973 of the mus musculus 5-HT4 receptor cDNA (GenBank accession no. NM_008313). The final concentration of the primers was 0.2 M. After denaturation at 94°C for 3 min, 35 cycles of PCR amplification were performed (94°C, 40 s; 55°C, 60 s; 72°C, 80 s). The last cycle included 10 min of final extension at 72°C. Two types of negative control (without template DNA and where reverse transcriptase was omitted) were included in every experiment, in which no PCR product was detected. Ten microliters of each PCR product was electrophoresed on a 1.2% agarose gel containing ethidium bromide. Resulting gel bands were visualized in a UV transilluminator, and images were captured by using a camera. Identification of 5-HT4 receptor expression was based on observation of an RT-PCR product of appropriate size (ϳ412 bp).
Statistics. All results are expressed as means Ϯ SE. Net peak bicarbonate and net peak Isc both refer to stimulated peak responses minus basal levels. Data were analyzed by one-way ANOVA followed by Newman-Keuls post hoc test. P Ͻ 0.05 was considered statistically significant.
RESULTS

Effect of cAMP-, Ca
2ϩ -, and cGMP-dependent signaling pathway inhibitors on 5-HT-stimulated duodenal mucosal bicarbonate secretion and I sc . We first sought to identify signaling pathway(s) that might underlie the effect of 5-HT on duodenal mucosal bicarbonate secretion. To accomplish this, a pharmacological approach was taken. Thus the adenylyl cyclase inhibitor MDL-12330A (10 Ϫ5 M), the cAMP antagonist Rp-cAMP (10 Ϫ4 M), and the cAMP-dependent PKA inhibitor H-89 (10 Ϫ5 M) all markedly inhibited 5-HT-stimulated duodenal bicarbonate secretion and I sc (P Ͻ 0.001) (Fig. 1) . Likewise, the Ca 2ϩ channel blocker verapamil (5 ϫ 10 Ϫ5 M) and the calmodulin antagonist W-13 (5 ϫ 10 Ϫ5 M) also markedly inhibited 5-HT-stimulated duodenal bicarbonate secretion and I sc (P Ͻ 0.01), whereas the Ca 2ϩ /camodulin-dependent protein kinase (CaM-PK) inhibitor KN-62 did not reduce 5-HT-stimulated duodenal bicarbonate secretion or I sc (Fig. 2 ). In contrast, neither the guanylyl cyclase inhibitor NS-2028 (10 Ϫ5 M) nor the cGMP-dependent PKG inhibitor KT-5823 (5 ϫ 10 Ϫ6 M), which can effectively inhibit guanylyl cyclase and PKG, respectively, at these concentrations (16, 43) , reduced 5-HTstimulated duodenal bicarbonate secretion or I sc (Fig. 3) . Ϫ6 M, respectively, for elevating bicarbonate secretion and I sc , respectively (Fig. 7) . RS-67506 was less efficacious than 5-HT. The net maximal increases in duodenal bicarbonate secretion and I sc induced by RS-67506 (10 Ϫ4 M) were equivalent to 67.4 and 49.6% of those evoked by the same concentration of 5-HT, respectively (Fig. 6) . 4 receptor mRNA in murine duodenal mucosa and epithelial cells. The pharmacological studies described above indicated that 5-HT 4 receptors mediate the effect of 5-HT on both duodenal mucosal bicarbonate secretion and I sc . To confirm that this receptor subtype is present in the murine duodenum, we assessed the expression of 5-HT 4 receptor mRNA in duodenal mucosa and epithelial cells by using RT-PCR. Figure 8 receptors. The location of the bands for 5-HT 4 receptors corresponds to the expected amplified cDNA fragment size based on the choice of oligonucleotide primers. 5-HT 4 receptor RT-PCR product was detected, indicating that functional 5-HT 4 receptors likely exist in murine duodenal mucosa and epithelial cells.
Effects of 5-HT receptor antagonists on 5-HT-stimulated
Expression of 5-HT
DISCUSSION
In a previous study (46) , we found that 5-HT is a potent stimulant of duodenal mucosal bicarbonate secretion. However, the intracellular signaling transduction pathways underlying the 5-HT-induced duodenal secretory response had not been investigated. Bicarbonate is secreted in response to a number of agonists via the activation of various signal transduction pathways. cAMP, Ca 2ϩ , and cGMP are three important intracellular modulators of duodenal mucosal bicarbonate secretion (12) . We thus examined the role of cAMP-, Ca 2ϩ -, and cGMP-dependent signaling pathways in 5-HT-induced duodenal bicarbonate secretion. Our results demonstrated that an adenylyl cyclase inhibitor, a cAMP antagonist, and a PKA inhibitor markedly reduced 5-HT-stimulated duodenal bicarbonate secretion and I sc . Likewise, a Ca 2ϩ channel blocker and a calmodulin inhibitor, but not a CaM-PK inhibitor, also markedly reduced 5-HT-stimulated duodenal bicarbonate secretion and I sc . However, a guanylyl cyclase inhibitor and a PKG inhibitor failed to alter 5-HT-stimulated bicarbonate se- cretion and I sc . These results indicated that 5-HT likely stimulates duodenal mucosal bicarbonate secretion via both cAMPand Ca 2ϩ -dependent signaling pathways, but the Ca 2ϩ signaling pathway is independent of CaM-PK. cAMP is a predominant signaling pathway in duodenal bicarbonate secretion, and indeed inhibition of this pathway had a greater effect on bicarbonate secretion than did modulation of calcium-related signaling. In a study of epididymal epithelial cells, Leung et al. (29) found that 5-HT increased intracellular cAMP concentrations and stimulated anion secretion via the activation of cAMP-dependent signal transduction pathways. 5-HT also increased cytosolic Ca 2ϩ in rat heart endothelial cells (26) and stimulated net Ca 2ϩ flux in the ventricular muscle of a mollusc (10). In addition, in our previous study in this model (46), we found that 5-HT stimulated the release of ACh from duodenal mucosa in mice. ACh is known to stimulate cell secretion mainly by increasing cellular Ca 2ϩ levels (11, 32) . We therefore conclude that 5-HT stimulates duodenal bicarbonate secretion via increases in duodenal cAMP and Ca 2ϩ concentrations but acts independently of cGMP-dependent pathways. However, it remains unknown whether these signaling events occur at the level of the epithelium exclusively or also involve indirect pathways requiring additional cell types.
We further studied the 5-HT receptor subtypes involved in the action of 5-HT. This study demonstrated that the 5-HT 1 receptor antagonist methiothepine or the 5-HT 2 receptor antagonist ketanserin failed to inhibit 5-HT-induced duodenal bicarbonate secretion or I sc . Likewise, a low concentration of ICS-205930 (10 Ϫ7 M), at which it is known to act as a 5-HT 3 receptor antagonist (39, 41) , had no effect on 5-HT-induced duodenal bicarbonate secretion or I sc . However, a high concentration of ICS-205930 (10 Ϫ5 M), at which it is known to antagonize 5-HT 4 not yet clear. In our previous study using the same model of murine duodenum in vitro (46), we found that 5-HT-stimulated duodenal bicarbonate secretion was partially inhibited by the neurotoxin TTX and cholinergic receptor antagonist atropine, indicating that 5-HT-stimulated duodenal bicarbonate secretion in mice involves both neural and nonneural pathways. For the case of intestinal chloride secretion, some studies showed that 5-HT 4 receptors mediate chloride secretion via a nonneural pathway (5-7), whereas the 5-HT 3 receptor appears to be the primary receptor mediating effects dependent on the enteric nervous system (5). However, in the guinea pig isolated ileal mucosal preparation, 5-HT 4 receptor mediated chloride secretion via TTX-sensitive mechanism (28) . These findings suggest that secretory responses to 5-HT 4 receptor ligation are mediated both neuronally and nonneuronally. In this study, we demonstrated that the 5-HT 4 receptor alone appears to mediate 5-HT-stimulated duodenal bicarbonate secretion. Considering our previous results in this model (46) , we can speculate that the 5-HT 4 receptor mediates 5-HT-stimulated duodenal bicarbonate secretion in mice by both neural and nonneural pathways.
Some studies have shown that the stimulation of 5-HT 4 receptors facilitates the release of ACh from not only the central nervous system (8, 38) but also from enteric nerve terminals (24, 25) . In our previous study in this model (46), we also found that 5-HT stimulates the release of ACh from duodenal mucosa in mice. ACh is an important neurotransmitter and plays an important role in the regulation of both duodenal bicarbonate secretion (20) and intestinal chloride secretion (9). Therefore, it is possible that the 5-HT 4 receptor mediates duodenal mucosal bicarbonate by stimulating localized mucosal cholinergic neurons. On the other hand, the 5-HT 4 receptor is a member of the superfamily of G proteincoupled receptors and is positively coupled to adenylate cyclase (4, 18) . It has been demonstrated that the activation of 5-HT 4 receptors augments adenylate cyclase activity and elevates cAMP levels in rat esophagus (14) and human colon (30) . Likewise, in isolated mucosal cells from rat distal colon, the study of Albuquerque et al. (2) demonstrated that 5-HT acts at a 5-HT 4 receptor to induce production of cAMP in rat distal crypt colonocytes. Our RT-PCR study demonstrated that 5-HT 4 receptor mRNA are expressed not only in the duodenal mucosa as a whole but also likely in duodenal epithelial cells, indicating that functional 5-HT 4 receptors may exist in duodenal mucosa and epithelial cells. Therefore, 5-HT may act directly at 5-HT 4 receptors on epithelial cells to induce cAMP production and regulate duodenal bicarbonate secretion. Our signal transduction data are likewise consistent with a direct effect of 5-HT mediated by cAMP and by an indirect effect, involving the known Ca 2ϩ -dependent secretagogue ACh, mediated by calcium.
5-HT 3 receptors are found on neurons of both central and peripheral origin. In the periphery, they are located on pre-and postganglionic autonomic neurons and on neurons of the sensory nervous system (22) . In addition to its pronounced effect on the cardiovascular system, the 5-HT 3 receptor also mediates the regulation of gastrointestinal motility and secretion. In the rat, 5-HT 3 receptors have been shown to mediate colonic chloride secretion via neural pathways (5, 41) . However, in the present study, we were unable to observe that the 5-HT 3 receptor antagonist, low-dose ICS-205930, influenced 5-HTstimulated duodenal bicarbonate secretion or that the 5-HT 3 receptor agonist phenylbiguanide had any stimulatory effect on duodenal bicarbonate secretion, suggesting that 5-HT 3 receptors may not participate in regulating duodenal bicarbonate secretion in mice. Likewise, the 5-HT 2 receptor antagonist ketanserin had no inhibitory effect on 5-HT-induced duodenal bicarbonate secretion and the 5-HT 2 receptor agonist ␣-methyl-5-HT had no stimulatory effect on duodenal bicarbonate secretion, suggesting that 5-HT 2 receptor is not involved in duodenal bicarbonate secretion in mice either. Other reports showed that ketanserin inhibits 5-HT-induced secretion in rat colon (40) and rat jejunum (3). The differences among these results indicate that the function of 5-HT receptors depends on the species and anatomic region. In fact, the 5-HT 1 receptor is comprised of five receptor subtypes. Some of these subtypes exist in the gastrointestinal tract (17, 35) . However, at present, it has not been reported that the 5-HT 1 receptor is involved in regulation of intestinal secretion. In this study, our results also demonstrated that the 5-HT 1 receptor did not mediate duodenal bicarbonate secretion.
In conclusion, our results demonstrated that 5-HT stimulates duodenal bicarbonate secretion via a 5-HT 4 receptor and both cAMP-and Ca 2ϩ -dependent signal pathways. RT-PCR confirmed that 5-HT 4 receptor mRNAs are expressed in duodenal mucosa and epithelial cells, indicating that functional 5-HT 4 receptors may exist in epithelial and perhaps also subepithelial compartments.
